CorMedix (CRMD)
(Delayed Data from NSDQ)
$11.64 USD
-0.03 (-0.26%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $11.64 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
CorMedix Inc's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CRMD 11.64 -0.03(-0.26%)
Will CRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRMD
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
CRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
Other News for CRMD
March 2026 Options Now Available For CorMedix (CRMD)
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
CRMD Downgraded to Hold by D. Boral Capital | CRMD Stock News
Circle initiated, Disney upgraded: Wall Street's top analyst calls
CorMedix just downgraded at D. Boral Capital, here's why